Myrexis, Inc. (MYRX)

[sandtrap246]

The last 10Q seems to indicate a suspension of development activities, and a transfer to 'third parties'...

We expect to continue to see reduced research and development costs as a result of the decision to suspend further development activities for all preclinical and clinical programs and as a result of the transfer of all preclinical and clinical programs to third parties

SS also indicated (as of 31 Dec 2012):

AS: 60 mil
OS: 27 mil

8K says Ernst & Young resigning. (De-listed company - no prestige or credibility.)

The schedule 13G seems to indicate that some outside investors have taken a substantial position in this stock.

Form 25-NSE - formal declaration of delisting from the NASDAQ effective 1 March 2013.

This is what I'm gathering from the filings...if you find I'm in error, please let me know.

The upsurge in volume today makes me suspect something else is going on behind the scenes.

Opinions?